Andrew Krumerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew Krumerman has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Luigi Di Biase
Montefiore Einstein Center for Heart and Vascular Care, Montefiore Medical Center , Bronx, NY, 10467
14 shared publications Faraj Kargoli
Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, United States of America
11 shared publicationsKevin Ferrick
Department of Medicine, Division of Cardiology Montefiore Medical Center/Albert Einstein College of Medicine Bronx New York USA
10 shared publications- Eric Shulman
Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, New York
8 shared publications - John D. Fisher
Division of Cardiology, Department of Medicine Montefiore Einstein Medical Center, Albert Einstein College of Medicine Bronx New York USA
8 shared publications John Fisher
Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, United States
8 shared publications
Latest Publications
- 7 November 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (1) , 276-285
Catheter Ablation of Atrial Fibrillation in Infiltrative Cardiomyopathies: A Narrative Review
Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. This review discusses ablative techniques for arrhythmias in amyloidosis, sarcoidosis, hemochromatosis, and glycogen storage disorders, primarily focusing on atrial fibrillation (AF). A thorough literature review was conducted on the MEDLINE database to synthesize current knowledge and propose future research directions. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation. While catheter ablation is associated with a significantly lower rate of all‐cause mortality and admission rate, conflicting data exist regarding the higher risk of pericardial effusion, in‐hospital mortality, length of stay, and cost of hospitalization. Cardiac sarcoid predisposes AF due to granulomas, atrial dilation, and scarring. Studies demonstrate encouraging outcomes and low recurrence rates in these patients who undergo ablation for AF, with no difference in complications compared to those without sarcoidosis. AF is the most common arrhythmia in hereditary hemochromatosis (HH), secondary to increased myocardial iron stores and elevated oxidative stress, and is primarily managed by chelation. Scant reports regarding ablation are described for HH and glycogen storage disorders. Catheter ablation is a safe and effective modality for the treatment of AF in infiltrative cardiomyopathy. Future large‐scale trials are needed to confirm these findings.
- 7 November 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (1) , 276-285
Catheter Ablation of Atrial Fibrillation in Infiltrative Cardiomyopathies: A Narrative Review
Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. This review discusses ablative techniques for arrhythmias in amyloidosis, sarcoidosis, hemochromatosis, and glycogen storage disorders, primarily focusing on atrial fibrillation (AF). A thorough literature review was conducted on the MEDLINE database to synthesize current knowledge and propose future research directions. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation. While catheter ablation is associated with a significantly lower rate of all‐cause mortality and admission rate, conflicting data exist regarding the higher risk of pericardial effusion, in‐hospital mortality, length of stay, and cost of hospitalization. Cardiac sarcoid predisposes AF due to granulomas, atrial dilation, and scarring. Studies demonstrate encouraging outcomes and low recurrence rates in these patients who undergo ablation for AF, with no difference in complications compared to those without sarcoidosis. AF is the most common arrhythmia in hereditary hemochromatosis (HH), secondary to increased myocardial iron stores and elevated oxidative stress, and is primarily managed by chelation. Scant reports regarding ablation are described for HH and glycogen storage disorders. Catheter ablation is a safe and effective modality for the treatment of AF in infiltrative cardiomyopathy. Future large‐scale trials are needed to confirm these findings.
- 10 November 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 16 (2) , 163-168
Accidental Conduction System Pacing in Patient with Displaced Cardiac Resynchronization Therapy Leads
- 10 November 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 16 (2) , 163-168
Accidental Conduction System Pacing in Patient with Displaced Cardiac Resynchronization Therapy Leads
- 7 November 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 16 (2) , 169-174
Atrial Tachycardia Masquerading as Atrial Fibrillation Following Bi-Atrial MAZE Procedure
- 7 November 2023
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 16 (2) , 169-174
Atrial Tachycardia Masquerading as Atrial Fibrillation Following Bi-Atrial MAZE Procedure
- Open Access
- 23 September 2022
- Published by Science Repository OU in Journal of Integrative Cardiology Open Access
- Vol. 2022 (3) , 1-4
Accuracy of a Single Versus Multiple Trials of Novel Pacemaker ID Algorithm Mobile Phone App for Identification of Cardiac Devices
Fast and accurate identification of cardiac devices can facilitate device programming and interrogation in various medical settings. We have previously demonstrated the accuracy of the PacemakerID machine learning algorithm for mobile phone cardiac device identification. However, the questions of the reproducibility of this algorithm and whether a single trial sufficiently maximizes accuracy have yet to be answered. Here, we examine 502 chest x-rays performed at a single institution on patients with implantable cardioverter-defibrillators and permanent pacemakers. The PacemakerID mobile phone application was used for five sequential trials on each image and the accuracy of one, three, and five trials were compared. A single trial resulted in a 79% accuracy and 82% positive predictive value with no significant difference (p=0.69) as compared to five trials at identifying device manufacturers. Across all devices, the results of a single trial were not significantly different from those of five trials. Our data demonstrate that a single trial is sufficient to maximize diagnostic accuracy with the PacemakerID mobile phone application, facilitating rapid identification for prompt programming and interrogation of cardiac devices.
- 23 September 2022
- Published by Science Repository OU in Journal of Integrative Cardiology Open Access
- Vol. 2022 (3) , 1-4
Open AccessAccuracy of a Single Versus Multiple Trials of Novel Pacemaker ID Algorithm Mobile Phone App for Identification of Cardiac Devices
Fast and accurate identification of cardiac devices can facilitate device programming and interrogation in various medical settings. We have previously demonstrated the accuracy of the PacemakerID machine learning algorithm for mobile phone cardiac device identification. However, the questions of the reproducibility of this algorithm and whether a single trial sufficiently maximizes accuracy have yet to be answered. Here, we examine 502 chest x-rays performed at a single institution on patients with implantable cardioverter-defibrillators and permanent pacemakers. The PacemakerID mobile phone application was used for five sequential trials on each image and the accuracy of one, three, and five trials were compared. A single trial resulted in a 79% accuracy and 82% positive predictive value with no significant difference (p=0.69) as compared to five trials at identifying device manufacturers. Across all devices, the results of a single trial were not significantly different from those of five trials. Our data demonstrate that a single trial is sufficient to maximize diagnostic accuracy with the PacemakerID mobile phone application, facilitating rapid identification for prompt programming and interrogation of cardiac devices.
- 4 August 2022
- Published by Elsevier in Heart Rhythm
- Vol. 19 (11) , 1918-1919
Smartwatch failure to record a single-lead electrocardiogram after conduction system pacing: A case series
- 4 August 2022
- Published by Elsevier in Heart Rhythm
- Vol. 19 (11) , 1918-1919
Smartwatch failure to record a single-lead electrocardiogram after conduction system pacing: A case series
- Open Access
- 14 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Arrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system
Background: Coronavirus infection (COVID-19) is the cause of the current world-wide pandemic. Cardiovascular complications occur in 20–30% of patients with COVID-19 infection including myocardial injury and arrhythmias. Current understanding of specific arrhythmia type and frequency is limited. In response to COVID-19 pandemic and overwhelmed hospital critical care and telemetry recourses, patch-based cardiac monitoring system received emergency Food and Drug Administration (FDA) approval for inpatient monitoring. A patch-based cardiac telemetry system has been shown to be useful for patient management during the COVID-19 pandemic and provides detailed analysis of cardiac rhythms. Purpose: To analyze arrhythmia type and frequency in patients with COVID-19 infection, identifying arrhythmia patterns over time during hospitalization and after discharge. Methods: A prospective cohort study during the COVID-19 pandemic was performed. We included patients hospitalized with COVID-19 infection who had a patch-based mobile telemetry device placed for cardiac monitoring. A quantitative analysis including type, frequency and duration of detected arrhythmias was performed at the end of the monitoring period. Results: A total of 103 patients hospitalized with COVID-19 diagnosis underwent monitoring. Quantitative reports for 59 patients were available for analysis, among those 59% were males, median age 65 (IQR 56–76) yrs. Mean wear time was 6.8±5.0 days. Arrhythmias were detected in 72.9% of patients. Majority of arrhythmias were SVT (59.3% of patients) and AF (22.0%). Episodes of AF duration >30 min were detected in 12 patients. New onset AF was noted in 15.0% of patients and was significantly associated with age (OR 1.4 for 5 yrs difference; 95% CI 1.01–2.05). Brady arrhythmias (2nd degree, 3rd degree AV bock, pause≥3 seconds) were seen in 18.7% of patients. Arrhythmias were consistently detected throughout the monitoring period in 52.9%-89.5% of patients daily (Figure 1). In 9 patients who were discharged with continued patch monitoring, 3 patients (33.3%) had arrhythmic events during their outpatient monitoring period. Conclusion: A majority of patients hospitalized with COVID-19 infection had arrhythmias detected by patch cardiac monitor. Arrhythmias were observed throughout hospitalization with a consistent daily frequency. Patients continued to exhibit cardiac arrhythmias after hospital discharge of a type similar to that seen during hospitalization. New onset AF often occurred and was associated with older age. Inpatient application of a patch cardiac telemetry with continued monitoring as outpatient is feasible and effective in detecting occult arrhythmias in patients with COVID-19 infection. Funding Acknowledgement: Type of funding sources: None. Daily frequency of arrhythmias detected
- 14 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Open AccessArrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system
Background: Coronavirus infection (COVID-19) is the cause of the current world-wide pandemic. Cardiovascular complications occur in 20–30% of patients with COVID-19 infection including myocardial injury and arrhythmias. Current understanding of specific arrhythmia type and frequency is limited. In response to COVID-19 pandemic and overwhelmed hospital critical care and telemetry recourses, patch-based cardiac monitoring system received emergency Food and Drug Administration (FDA) approval for inpatient monitoring. A patch-based cardiac telemetry system has been shown to be useful for patient management during the COVID-19 pandemic and provides detailed analysis of cardiac rhythms. Purpose: To analyze arrhythmia type and frequency in patients with COVID-19 infection, identifying arrhythmia patterns over time during hospitalization and after discharge. Methods: A prospective cohort study during the COVID-19 pandemic was performed. We included patients hospitalized with COVID-19 infection who had a patch-based mobile telemetry device placed for cardiac monitoring. A quantitative analysis including type, frequency and duration of detected arrhythmias was performed at the end of the monitoring period. Results: A total of 103 patients hospitalized with COVID-19 diagnosis underwent monitoring. Quantitative reports for 59 patients were available for analysis, among those 59% were males, median age 65 (IQR 56–76) yrs. Mean wear time was 6.8±5.0 days. Arrhythmias were detected in 72.9% of patients. Majority of arrhythmias were SVT (59.3% of patients) and AF (22.0%). Episodes of AF duration >30 min were detected in 12 patients. New onset AF was noted in 15.0% of patients and was significantly associated with age (OR 1.4 for 5 yrs difference; 95% CI 1.01–2.05). Brady arrhythmias (2nd degree, 3rd degree AV bock, pause≥3 seconds) were seen in 18.7% of patients. Arrhythmias were consistently detected throughout the monitoring period in 52.9%-89.5% of patients daily (Figure 1). In 9 patients who were discharged with continued patch monitoring, 3 patients (33.3%) had arrhythmic events during their outpatient monitoring period. Conclusion: A majority of patients hospitalized with COVID-19 infection had arrhythmias detected by patch cardiac monitor. Arrhythmias were observed throughout hospitalization with a consistent daily frequency. Patients continued to exhibit cardiac arrhythmias after hospital discharge of a type similar to that seen during hospitalization. New onset AF often occurred and was associated with older age. Inpatient application of a patch cardiac telemetry with continued monitoring as outpatient is feasible and effective in detecting occult arrhythmias in patients with COVID-19 infection. Funding Acknowledgement: Type of funding sources: None. Daily frequency of arrhythmias detected
- Open Access
- 1 September 2021
- Published by AME Publishing Company in Journal of Medical Artificial Intelligence
- Vol. 4, 6
Machine learning in atrial fibrillation—racial bias and a call for caution
- 1 September 2021
- Published by AME Publishing Company in Journal of Medical Artificial Intelligence
- Vol. 4, 6
Open AccessMachine learning in atrial fibrillation—racial bias and a call for caution
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , 1326-1335
Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , 1326-1335
Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation
- 1 December 2020
- Published by Elsevier in Heart Rhythm
- Vol. 17 (12) , 2119-2125
Determining the optimal duration for premature ventricular contraction monitoring
- 1 December 2020
- Published by Elsevier in Heart Rhythm
- Vol. 17 (12) , 2119-2125
Determining the optimal duration for premature ventricular contraction monitoring
- 15 September 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (9) , 2877-2879
Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation
- 15 September 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (9) , 2877-2879
Oral Anticoagulant Use in a Racial and Ethnically Diverse Population with Atrial Fibrillation